|
Volumn 34, Issue 6, 2002, Pages 2131-2132
|
Lamivudine in renal transplant candidates with chronic hepatitis B infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE;
DNA;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
HEPATITIS C ANTIBODY;
LAMIVUDINE;
TRANSFERASE;
ADULT;
CHRONIC HEPATITIS;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
HEMODIALYSIS;
HEPATITIS B;
HEPATITIS B VIRUS;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
KIDNEY TRANSPLANTATION;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
MALE;
POLYMERASE CHAIN REACTION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RECURRENT INFECTION;
SURGICAL TECHNIQUE;
ADULT;
ALANINE TRANSAMINASE;
ANTIVIRAL AGENTS;
FEMALE;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B, CHRONIC;
HEPATITIS C ANTIBODIES;
HUMANS;
KIDNEY TRANSPLANTATION;
LAMIVUDINE;
MALE;
MIDDLE AGED;
SAFETY;
|
EID: 0036755268
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02879-8 Document Type: Conference Paper |
Times cited : (17)
|
References (12)
|